Investors Capital Advisory Services’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Investors Capital Advisory Services’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,000	Closed	-$14K	–	764
2015 Q3	$14K	Sell	1,000 -500	-33%	-$8.64K	﹤0.01%	712
2015 Q2	$29K	Sell	1,500 -590	-28%	-$11.4K	0.01%	717
2015 Q1	$37K	Buy	2,090 +620	+42%	+$14K	0.01%	714
2014 Q4	$34K	Sell	1,470 -225	-13%	-$5.2K	0.01%	695
2014 Q3	$41K	Buy	1,695 +60	+4%	+$1.56K	0.01%	673
2014 Q2	$45K	Sell	1,635 -60	-4%	-$1.8K	0.01%	678
2014 Q1	$57K	Sell	1,695 -30	-2%	-$1.02K	0.01%	635
2013 Q4	$32K	Buy	1,725 +440	+34%	+$8.01K	0.01%	629
2013 Q3	$20K	Sell	1,285 -675	-34%	-$7.82K	0.01%	591
2013 Q2	$20K	Buy	+1,960	New	+$23K	0.01%	545

Other funds holding CTIC

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return